Company Filing History:
Years Active: 2005
Title: Irvin M Lash: Innovator of Pearlescent Film Coating Systems
Introduction
Irvin M Lash is a noteworthy inventor based in Pennsburg, PA, recognized for his advancements in film coating technologies. With a patent to his name, he has made significant contributions to the field of oral dosage forms. His innovative work has the potential to enhance the quality and aesthetic appeal of pharmaceutical products.
Latest Patents
Irvin Lash holds a patent for his invention titled "Pearlescent film coating systems and substrates coated therewith." This patent focuses on film coating systems designed for use on oral dosage forms like compressed tablets and orally-ingestible substrates. The invention aims to provide improved pearlescent qualities to these products through a specific formulation. The film coating systems can be applied directly to substrates or over a subcoat, demonstrating versatility in application methods. Notably, the pearlescent film coating is formulated as a dry powder mixture containing a cellulosic polymer, a detackifier, a gloss enhancer, and a pearlescent pigment.
Career Highlights
Irvin M Lash is associated with Bpsi Holdings, Inc., where he continues to contribute to the development of innovative solutions in the pharmaceutical sector. His work at the company reflects his dedication to enhancing product formulations and overall quality.
Collaborations
Throughout his career, Lash has collaborated with notable colleagues including Rita M Steffenino and Franklin J Gulian. These partnerships highlight the collaborative nature of innovation, where shared knowledge and expertise lead to groundbreaking inventions.
Conclusion
Irvin M Lash's work in the field of pearlescent film coatings underscores the importance of innovation in the pharmaceutical industry. With his patented technology, he strives to improve the visual and functional qualities of oral dosage forms, setting a standard for future developments. His contributions not only reflect his expertise but also enhance consumer experiences in the pharmaceutical market.